Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02200848 · TERMINATED
Trial details
- NCT number
- NCT02200848
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-03-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.